Clinical Trial

Utility of PCD Diagnostics to Improve Clinical Care

Study acronym: PCD
Recruiting
View on ClinicalTrials.gov →
Summary
This cross-sectional and longitudinal observational study is to gather data on the utility of tests that are used to make a diagnosis of primary ciliary dyskinesia (PCD). There is new testing available, called nasal nitric oxide testing, that non-invasively measures nitric oxide levels in the sinus cavity. Individuals with PCD characteristically have low levels, but this testing does not have extensive data from everyday clinical practice. The objective of this proposal is to improve the diagnostic approach to children and adults with clinical concerns for primary ciliary dyskinesia (PCD).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-06-02; most recent amendment 2025-09-19.
Status change: Not Yet Recruiting → Recruiting 2023-09-28
Trial Details
NCT Number NCT05889013
Lead Sponsor Connecticut Children's Medical Center
Collaborators: UConn Health
Conditions Primary Ciliary Dyskinesia
Enrollment 50 participants
Start Date 2023-10-17
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-22